Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-16

FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for naloxone hydrochloride from Par Health USA, LLC under ANDA215964. The action confirms approval of the generic produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)